new CCFA Community: Join the Discussion!
Sign up for CCFA's Free
E-mail Newsletter:
About CCFA
Living with IBD
Information Resource Center
CCFA Community
Disease Information
How You Can Help
Research
Chapters & Events
Kids & Teens
Advocacy
Science & Professionals
Research Grant Opportunities
IBD Meetings
Educational Resources
Clinical Resources
Research Resources
Professional Education Opportunities
IBD Journal
Shop CCFA
E-mail
Password
Remember
my Login

Enter Keyword(s):
Google Custom Search

donate

join

find clinical trials

find physicians

corporate partners

contact us

press

site map

IBD Journal

Inflammatory Bowel Diseases® is the first journal dedicated exclusively to IBD. It covers topics of interest to the professional clinician or researcher in this burgeoning field. Each monthly issue features original, peer-reviewed articles in clinical and basic science areas, as well as invited in-depth reviews of key treatment issues and groundbreaking research. Coverage includes articles highlighting the unique and important issues in pediatric IBD, as well as articles pertaining to adult patients. Also included are critical examinations of the design and results of recent clinical trials; elucidative discussions of controversial diagnostic and management issues and techniques; and summaries of significant articles from around the world with relevant commentary by experts in the field.

Inflammatory Bowel Diseases® is a benefit of Professional Membership in CCFA (at some membership levels). The cost of a Professional Membership is less than a stand-alone subscription to the journal.

The journal is also accessible online to subscribers.

ATTENTION CCFA MEMBERS: Access to IBD on Wiley InterScience (www.ibdjournal.com) requires an easy registration process. If you did not receive instructions with your first 2007 issues of IBD, or require assistance, please contact Lucy Woo, Membership Coordinator, lwoo@wiley.com

Selections from the November 2007 Issue

Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor œ agents (p 1323-1332)
Andrew Nesbitt, Gianluca Fossati, Marianne Bergin, Paul Stephens, Sue Stephens, Roly Foulkes, Derek Brown, Martyn Robinson, Tim Bourne
Published Online July 16, 2007

Presence of a marked nonneuronal cholinergic system in human colon: Study of normal colon and colon in ulcerative colitis (p 1347-1356)
Maria Jönsson, Örjan Norrgård, Sture Forsgren
Published Online July 30, 2007

Long-term clinical results of ileocecal resection for Crohn's disease (p 1369-1373)
Garret Cullen, Aoibhlinn O'Toole, Denise Keegan, Kieran Sheahan, John M. Hyland, Diarmuid P. O'Donoghue
Published Online: June 28, 2007

Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years (p 1395-1400)
Francesc Casellas, Luis Rodrigo, Pilar Niño, Carmen Pantiga, Sabino Riestra, Juan-Ramon Malagelada
Published Online: June 13, 2007

Selections from the December 2007 Issue

IBD Serological Panels: Facts and Perspectives (PDF)
Laurent Peyrin-Biroulet, Annie Standaert-Vitse, Julien Branche, and Mathias Chamaillard
Published Online: July 16, 2007

What Predicts Mucosal Inflammation in Crohn's Disease Patients? (PDF)
Itta M. Minderhoud, Melvin Samsom, and Bas Oldenburg
Published Online: July 30, 2007

Dual-association of gnotobiotic Il-10-/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis (p 1457-1466)
Sandra C. Kim, Susan L. Tonkonogy, Thomas Karrasch, Christian Jobin, R. Balfour Sartor
Published Online: August 30, 2007

Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn's disease: A prospective study (p 1493-1501)
Takayuki Yamamoto, Maki Nakahigashi, Abbi R. Saniabadi, Takashi Iwata, Yasuki Maruyama, Satoru Umegae, Koichi Matsumoto
Published Online: September 18, 2007

Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibility (p 1509-1515)
Arie Levine, Subra Kugathasan, Vito Annese, Vincent Biank, Esther Leshinsky-Silver, Ofir Davidovich, Gad Kimmel, Ron Shamir, Palmieri Orazio, Amir Karban, Ulrich Broeckel, Salvatore Cucchiara
Published Online: August 30, 2007

Rising hospitalization rates for inflammatory bowel disease in the United Statesbetween 1998 and 2004 (p 1529-1535)
Geoffrey C. Nguyen, Anne Tuskey, Themistocles Dassopoulos, Mary L. Harris, Steven R. Brant
Published Online: September 7, 2007

Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease (p 1536-1544)
Jonas Halfvarson, Tine Jess, Lennart Bodin, Gunnar Järnerot, Pia Munkholm, Vibeke Binder, Curt Tysk
Published Online: September 7, 2007

Selections from the January 2007 Issue

Patient Perceptions of the Risks and Benefits of Infliximab for the Treatment of Inflammatory Bowel Disease (PDF)
Corey A. Siegel, L. Campbell Levy, Todd A. MacKenzie, and Bruce E. Sands
Published Online: October 9, 2007

Role of Vascular Endothelial Growth Factor and Angiopoietin Systems in Serum of Crohn's Disease Patients (PDF)
Ines D. Pousa, Jose Mate, Xamila Salcedo-Mora, Maria T. Abreu, Ricardo Moreno-Otero, and Javier P. Gisbert
Published Online: September 18, 2007

For Authors...
Submit a manuscript to the IBD Journal
How to prepare a manuscript for submission

updated 5/13/08